Prolacta Bioscience celebrated Breastfeeding Awareness Month by recognizing the commitment of NICU parents to the health of their infants
DUARTE, Calif., August 29, 2022 /PRNewswire/ — Prolacta Bioscience®, the world’s leading hospital-based supplier of 100% breastmilk-based nutritional products for critically ill preterm infants, celebrated Breastfeeding Awareness Month by recognizing the commitment of parents to NICU towards the health of their infants by defending and/or providing essential nutrition to breast milk.
Throughout Breastfeeding Awareness Month, Prolacta provided helpful breastfeeding tips through its social media channels to support new parents of premature babies. Prolacta Advice offered practical advice including breastfeeding advice, information on what to expect when returning to work, inspirational stories and more.
“Breastfeeding can be one of the hardest parts of being a new parent, especially when you’re in the neonatal intensive care unit,” Dr. Erin HamiltonSpence, director of clinical training at Prolacta. “It really is a labor of love and requires more time and effort than many realize. All parents, and especially those with infants in the NICU, should have the support they need. and the ability to give their babies the best nutrition for their health, i.e. mom’s milk, or donor breast milk when mom’s milk is not an option.”
Every August, Breastfeeding Awareness Month highlights the essential nutrition that breastmilk provides to premature babies. Recently, the American Academy of Pediatrics (AAP) shared new guidelines recommending exclusive breastfeeding for the first six months when possible, and included a recommendation to support parents who choose to breastfeed their babies until at 2 years of age and beyond due to continued health benefits.1
“Mom’s milk is the best nutrition for all infants for the first six months of life,” said Prolacta’s chief medical officer. Melinda J. Elliott, MD, FAAP. “We recognize that more needs to be done to support all parents, especially those who are breastfeeding. Breastfeeding takes a lot of time and effort, and we honor these parents for giving their babies the healing benefits of breast milk. We will continue to provide breastfeeding education and support to those in need.”
About Prolacta Bioscience
Prolacta Bioscience® Inc. is a privately held, global life sciences company dedicated to advancing the science of human milk® to improve the health of critically ill preterm infants. Prolacta’s 100% human milk nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals. More than 80,000 premature babies have benefited from Prolacta nutritional products worldwide to date.2 Founded in 1999, Prolacta is the world’s leading supplier of human milk-based nutritional products for hospital use and also explores the therapeutic potential of human milk in a wide range of diseases. Prolacta maintains the highest quality and safety standards in the industry for the screening, testing and processing of human donor milk. Operating the world’s first pharmaceutical-grade breast milk processing facility, Prolacta uses tank pasteurization and a patented, FDA-reviewed manufacturing process to ensure pathogen inactivation while protecting the nutritional composition and bioactivity of its breast milk products. Prolacta is a global company headquartered in Duarte, Californiaand can be found online at www.prolacta.com, at TwitterInstagram, Facebook and LinkedIn.
# # #
Media Contact:
Loren Kosmont
[email protected]
310-721-9444
References
- Meek JY, Noble L. Policy statement: Breastfeeding and the use of breastmilk. Pediatrician. 2022;150(1). doi:10.1542/peds.2022-057988
- Estimated number of premature babies fed with Prolacta products from January 2007 at December 2021; data on file.
SOURCEProlacta Bioscience
